Status:
COMPLETED
Totally Laparoscopic Distal Gastrectomy VS Pylorus-Preserving Gastrectomy for Early Gastric Cancer in the Middle Stomach
Lead Sponsor:
Changzhi Medical College
Conditions:
Gastrectomy
Eligibility:
All Genders
18-85 years
Brief Summary
With the development of laparoscopic technology, the surgical treatment of early gastric cancer (EGC) has shifted towards minimally invasive, precise, and function-preserving strategies. Totally lapar...
Detailed Description
With the continuous advancement and innovation of laparoscopic technology, the surgical treatment paradigm for early gastric cancer (EGC) is undergoing a profound transformation, gradually evolving to...
Eligibility Criteria
Inclusion
- Preoperative diagnosis of early gastric adenocarcinoma (invasion limited to the mucosa or submucosa) confirmed by tissue biopsy, abdominal enhanced CT, and endoscopic ultrasound;
- Tumor located in the gastric body or distal stomach, \>4 cm from the pylorus;
- Ineligible for endoscopic mucosal dissection or elected for surgical treatment by family;
- Complete clinical and pathological data.
Exclusion
- Severe anemia, coagulation disorders, or gastric outlet obstruction;
- History of gastric or upper abdominal surgery;
- Concurrent malignant tumors, ascites, edema, or pleural effusion;
- Gastric ulcers, polyps, or intestinal metaplasia.
Key Trial Info
Start Date :
January 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 1 2025
Estimated Enrollment :
95 Patients enrolled
Trial Details
Trial ID
NCT06970327
Start Date
January 1 2020
End Date
March 1 2025
Last Update
May 14 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
HeJi hospital affiliated ChangZhi medical college
Changzhi, Shanxi, China, 046000